Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate

被引：1

作者：

Jacopo Giuliani ^{[1
]}

Andrea Bonetti ^{[1
]}

机构：

[1] Department of Oncology,Mater Salutis Hospital-ASL 21 della Regione Veneto,Legnago (VR),Italy

来源：

Chinese Journal of Cancer Research | 2013年 / 25卷 / 05期

关键词：

GIST; Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate;

D O I：

暂无

中图分类号：

R735 [消化系肿瘤];

学科分类号：

100214 ;

摘要：

Gastrointestinal stromal tumor(GIST)is the most common mesenchymal malignancy of the gastrointestinal tract.GISTs may coexist with different types of cancer,either synchronous or metachronous(1).Most GISTs develop in a sporadic fashion,but familial occurrence,such as neurofibromatosis and Carney-triad,has also been reported(2).The overall frequency of second tumors in different series varied from

引用

页码：486 / 487

页数：2

共 50 条

[31] Imatinib mesylate in the treatment of gastrointestinal stromal tumour
Steinert, DM
McAuliffe, JC
Trent, JC
EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) : 105 - 113
[32] Imatinib mesylate for the treatment of gastrointestinal stromal tumor
Cassier, Philippe A.
Blay, Jean-Yves
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (05) : 623 - 634
[33] Efficacy of imatinib mesylate in from gastrointestinal stromal
Fiorentini, G
Bernardeschi, P
De Simone, M
Rossi, S
Dentico, P
Biancalani, M
Scuderi, S
Vaira, M
Palomba, A
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (04): : 13 - 16
[34] Imatinib mesylate - In the treatment of gastrointestinal stromal tumours
Croom, KF
Perry, CM
DRUGS, 2003, 63 (05) : 513 - 522
[35] Gastrointestinal carcinoid tumors and second primary malignancies
Habal, N
Sims, C
Bilchik, AJ
JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (04) : 301 - 306
[36] Surgical treatment of patients (pts) with gastrointestinal stromal tumors (GIST) after imatinib mesylate (IM) therapy.
Rutkowski, P
Nowecki, Z
Nyckowski, P
Dziewirski, W
Nasierowska-Guttmejer, A
Grzesiakowska, U
Michej, W
Krawczyk, M
Ruka, W
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 825S - 825S
[37] Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: A report of two cases
Hasan, S
Hassan, M
Oke, L
Dinh, K
Onojobi, G
Lombardo, F
Dawkins, F
Jack, M
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (12) : 1208 - 1210
[38] Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case
Ando, Koji
Oki, Eiji
Sugiyama, Masahiko
Zhao, Yan
Kojima, Aya
Yamamoto, Hidetaka
Yamashita, Yoichi
Saeki, Hiroshi
Taketomi, Akinobu
Morita, Masaru
Kakeji, Yoshihiro
Tsujitani, Shunichi
Maehara, Yoshihiko
SURGERY TODAY, 2011, 41 (09) : 1290 - 1293
[39] Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
Tonyali, Onder
Coskun, Ugur
Yildiz, Ramazan
Karakan, Tarkan
Demirci, Umut
Akyurek, Nalan
Benekli, Mustafa
Buyukberber, Suleyman
MEDICAL ONCOLOGY, 2010, 27 (03) : 768 - 773
[40] Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
Onder Tonyali
Ugur Coskun
Ramazan Yildiz
Tarkan Karakan
Umut Demirci
Nalan Akyurek
Mustafa Benekli
Suleyman Buyukberber
Medical Oncology, 2010, 27 : 768 - 773

← 1 2 3 4 5 →